• Energy security depends on more than pipelines, plants and reserves. It depends on experienced people who know how to run and manage them.
• Frontieras’s Mason County project is expected to create approximately 200 full-time jobs, with wages averaging three times the average income for the area, along with roughly 2,000 construction jobs during the build phase.
• The plant itself will process 7,500 tons of coal per day using FASForm(TM), the company’s Solid Carbon Fractionation process, producing diesel, naphtha, aviation fuel, hydrogen, methane and FASCarbon(TM), a clean-coal product.

A domestic energy project only strengthens the country if it first strengthens the community that builds it. In Point Pleasant, West Virginia, that is the promise behind Frontieras North America and its FASForm coal facility, a project the company says will bring approximately 200 full-time jobs and roughly 2,000 construction positions to Mason County.

Energy security depends on more than pipelines, plants and reserves. It requires people who know how to run and handle them. The United States has spent decades letting its domestic energy workforce shrink, particularly in coal country, and that erosion carries its own risk. A country cannot rebuild energy capacity quickly if it no longer has the trained labor pool to staff it.

Appalachia is a clear example of what that erosion looks like. Coal mining employment across the region fell from nearly 56,000 jobs in 2010 to about 28,000 in 2023, a nearly 50% decline in just over a decade. West Virginia alone employed 14,014 coal workers in 2023, down from tens of thousands a generation earlier. Every mine that closes displaces trained operators, engineers and technicians, and that expertise does not come back overnight once it is gone.

Rebuilding domestic energy capacity means rebuilding the workforce behind it at the same time. New industrial projects that hire and train locally do double duty: They add supply to the energy system, and they rebuild the skilled labor base the system depends on for the long run. Communities that have spent years watching energy jobs disappear are also the communities best positioned to staff the next generation of energy projects, provided the jobs actually show up.

That is the case Frontieras is making in Mason County. The company’s first commercial FASForm facility broke ground in Point Pleasant earlier this year, representing an estimated $850 million investment along the Ohio River. The project is expected to create approximately 200 full-time jobs, with wages averaging three times the average income for the area, along with roughly 2,000 construction jobs during the build phase.

“This groundbreaking marks a decisive step in the commercialization of FASForm(TM) and the return of serious industrial investment to America’s energy regions,” said Frontieras cofounder and CEO Matthew McKean. “We’re building a new class of energy infrastructure that extracts maximum value from domestic resources — profitably, at scale and with a zero-waste design.” For a county with an estimated population of about 24,700 people, a project of that size carries real weight.

Frontieras hired West Virginia native Robert Portz as vice president of operations and engineering to lead the plant through construction and startup. His role includes coordination with engineering firms, construction oversight, workforce development, and commissioning of the plant. Portz previously helped build one of the most profitable renewable diesel operations in Wyoming, and Frontieras selected him in part because of his refinery background and his ties to the state.

The plant itself will process 7,500 tons of coal per day using FASForm, the company’s Solid Carbon Fractionation process, producing diesel, naphtha, aviation fuel, hydrogen, methane and FASCarbon(TM), a clean-coal product. Frontieras did not choose Mason County randomly. The company has cited the county’s access to coal, skilled labor, and rail and water transportation as reasons it beat out competing sites in Texas and Wyoming.

State officials have framed the project as validation of the region’s labor pool. West Virginia Senator Eric Tarr described the current wave of investment in his district, which includes Frontieras alongside the nearby Nucor steel plant, as “a gold rush” for the area. Point Pleasant Mayor Amber Tatterson has said the city is now working to upgrade local infrastructure and utilities to keep pace with the growth.

For Mason County, the FASForm plant is a bet that a coal-fired workforce, given the right technology and the right jobs, still has plenty left to build. If the plant hires and trains at the scale Frontieras and county leaders expect, Point Pleasant will have more than a new employer on the Ohio River. It will have a template for how a coal community rebuilds its labor base around a new generation of coal technology, rather than watching that expertise leave for good.

For more information about Frontieras, visit the company’s website at www.Frontieras.com.

NOTE TO INVESTORS: The latest news and updates relating to Frontieras are available in the company’s newsroom at https://ibn.fm/Frontieras

• The economics of drone warfare are changing rapidly, with inexpensive unmanned systems creating an increasingly difficult cost equation for traditional counter-UAS defenses.
• At the same time, fiber-optic-guided and autonomous drones can operate without the radio-frequency emissions that many conventional detection and jamming approaches depend on.
• Wrap Technologies Inc. (NASDAQ: WRAP) is addressing both challenges through WrapShield(TM), combining Frenel Imaging Ltd.’s physics-based sensing technology with laser-directed energy for counter-UAS applications.

Drones have become an increasingly important tool in modern military operations, providing intelligence, surveillance and strike capabilities while reducing the need to put personnel directly in harm’s way. As these systems have become more accessible and sophisticated, however, they have also created a growing challenge for the technologies designed to stop them.

For counter-UAS operators, the problem is increasingly two-sided: How do you detect drones that are becoming harder to find, while also defeating them at a cost that makes sense?

The first challenge is economics.

Commercially available drones and components have lowered the cost of deploying unmanned systems, allowing adversaries to field large numbers of relatively inexpensive platforms. For defenders, using expensive interceptors or finite munitions against low-cost drones can quickly create an unfavorable cost exchange (ibn.fm/u5NUi).

Laser directed energy systems offer one potential way to change that equation. Unlike conventional interceptors, lasers can engage targets repeatedly without requiring a new physical munition for every shot, creating a fundamentally different cost structure. Although, reducing the cost of the engagement only addresses part of the problem.

A laser still needs to find the target, identify it and maintain an accurate aimpoint.

That makes detection increasingly important as drone technology evolves. Some conventional counter-UAS approaches rely heavily on radio-frequency signals to detect, track or disrupt unmanned aircraft. Yet fiber-optic-guided and preprogrammed autonomous systems can operate without maintaining the same type of RF connection, creating challenges for approaches built around detecting or disrupting those communications.

The question, then, becomes straightforward: How do you detect a drone that isn’t broadcasting a signal?

Building the Detection Layer

WRAP(R) is looking to address that challenge through its WrapShield(TM) platform, which the company describes as an autonomous defense and public-safety architecture designed to connect detection, AI-assisted decision support and response.

The platform’s detection layer is anchored by technology from Frenel Imaging, for which WRAP has secured exclusive U.S. and NATO commercialization rights to TPiCore(R) thermal-polarimetric imaging. Rather than depending on a drone’s communications, TPiCore(R) is designed to analyze the polarization of thermal radiation at the pixel level, providing information about an object’s physical characteristics and material composition.

That distinction is important.

A drone can change how it communicates, operate autonomously or use a fiber-optic connection, but its physical characteristics remain part of the target itself. By using a physics-based sensing approach, TPiCore(R) is designed to provide detection and classification capabilities without requiring an RF signal from the aircraft.

For WRAP, that technology provides more than another sensor. It establishes the perception layer needed to connect detection with an appropriate response.

From Detection to Engagement

In August, WRAP announced that laser counter-UAS technology was being added to WrapShield(TM), with Frenel’s passive thermal-polarimetric detection and classification technology serving as the perception and tracking layer for laser effector systems developed by an established directed-energy manufacturer.

The technology being advanced includes mobile and fixed-site fiber-laser configurations designed for repeated counter-UAS engagements. Because directed energy does not require a new physical interceptor for every engagement, the approach is intended to address the economics of sustained drone defense while providing a rapidly deployable response capability.

That integration is arguably the more important part of the story.

A sensor can identify a threat. A laser can engage one. But combining the two creates a broader counter-UAS workflow: detect the threat, classify it, track it, determine an appropriate response and then engage it.

As drone threats become cheaper, more autonomous and increasingly difficult to detect, counter-UAS systems face a growing two-sided challenge: finding threats that may operate outside traditional RF detection methods while responding to them in a cost-effective way.

WrapShield(TM) is being positioned to address both. By combining Frenel’s physics-based thermal-polarimetric sensing with AI-assisted decision support and laser-directed energy, WRAP is developing an integrated platform designed to detect, understand and respond to evolving drone threats, targeting what may be two of the counter-UAS market’s most important challenges: the detection gap and the cost gap.

For more information, visit the company’s website at wrap.com.

NOTE TO INVESTORS: The latest news and updates relating to WRAP are available in the company’s newsroom at https://ibn.fm/WRAP

About / Disclaimer

This article was produced by IBN Editorial Staff and is intended for informational purposes only. It is not investment advice and should not be relied upon as the basis for any investment decision. Statements attributed to Wrap Technologies, Inc. or its management, including any forward-looking statements regarding revenue growth, product development, or market opportunities, reflect the company’s views and are subject to risks and uncertainties; actual results may differ materially. Readers should conduct their own due diligence and consult a qualified professional. Additional company information is available at wrap.com.

• Completion of Sarfartoq acquisition announced following formal approval from Greenland government.
• The 2026 Skaergaard field season is now in its active phase and should generate results before the Arctic season ends.
• An updated Sarfartoq resource estimate is in progress, and AnorTech stake option is worth tracking closely.

Every small-cap mining stock eventually reaches a stretch where several catalysts line up in close succession. That stretch turns a quiet chart into something worth watching closely. For Greenland Mines (NASDAQ: GRML) that stretch is now. Four items are converging: the close of its rare earths acquisition following government approval, the end of a live Arctic drilling season, a pending resource update and an option that could nearly double a strategic equity stake. 

The first item became a reality with the company’s Sept. 1 completion of the Sarfartoq acquisition. Earlier this year, Greenland Mines signed a definitive agreement in May 2026 to acquire Neo North Star Resources Inc. Neo North Star owns the Sarfartoq neodymium-praseodymium rare earths project, and the company bought it from stockholders including Neo Performance Materials. Earlier this month, the government of Greenland formally approved the indirect transfer of the underlying mineral exploration license, clearing the way for the acquisition to be finalized.

“The Sarfartoq acquisition is closed, and one of the western world’s top-tier upstream rare earth magnet projects is now a Greenland Mines asset,” Greenland Mines president Dr. Bo Møller Stensgaard. “At 2025 consumption levels, the NdPr oxide we plan to produce from ST1 alone would represent roughly a third of all NdPr oxide refined outside China, in every one of the project’s nine scheduled operating years — and ST1 forms only a small part of a much larger system. Our technical team is back on the ground at Sarfartoq this month, and we move immediately from acquisition to further resource growth-development.

Second, the 2026 Skaergaard field season is now in its active phase and should generate results before the Arctic season ends. Support vessel Argus reached the project site in August. Diamond drill rigs supplied by contractor Nordisk Fundering, including two new heli-portable units, began operating shortly after. By mid-August, crews had recovered all HQ-diameter core needed for a planned multiton metallurgical bulk sample. The program then shifted to NQ-size core drilling for resource definition and geotechnical work for the rest of the season. The program is designed to upgrade the mineral resource and generate data needed to advance Skaergaard toward an initial assessment. Assay results and season-end summaries, typically released after Arctic field work wraps, are a natural catalyst window for the stock.

Third, an updated Sarfartoq resource estimate is in progress and worth tracking closely. In June 2026, the company engaged Tetra Tech Canada and GeoSim Services to prepare a new mineral resource estimate compliant with SEC Regulation S-K 1300. That work incorporates both historic data and drilling Neo Performance Materials completed between 2023 and 2025. The update was expected to be substantially complete by the end of this summer and is expected to underpin a future updated preliminary economic assessment.

For reference, Skaergaard’s own S-K 1300 conversion earlier this year moved indicated resources to 15.0 million palladium-equivalent ounces, a 31% increase over the previous 2022 estimate, according to the company. A comparable modernization at Sarfartoq, given the project’s historic 5.9 million tonne PEA-stage resource, could be a meaningful rerrating event once published.

Fourth, watch the AnorTech stake option. In June 2026, Greenland Mines entered a share exchange agreement with AnorTech Inc., a Greenland-focused developer of sustainable and high-purity alumina technology. The deal gave Greenland Mines an initial 9.9% equity position and grants a six-month option, running from closing, to acquire enough additional shares to bring the total stake to as much as 19.9%. That window falls within the final months of 2026. A decision on whether to exercise the option is a live catalyst worth watching, since it would deepen the company’s exposure to midstream critical-materials processing rather than just upstream extraction.

These key items give Greenland Mines a genuinely full catalyst calendar heading into year-end. A closed Sarfartoq deal, published drill results, an updated resource estimate and a resolved AnorTech option would mark significant progress across both sides of the business within a matter of months. But for investors tracking GRML, the next few months have potential for several long-running story threads to come together.

For more information, visit www.GreenlandMines.com.

NOTE TO INVESTORS: The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML

• Researchers across the field, from Duke University to Mayo Clinic, are increasingly focused on restoring damaged cartilage rather than simply managing the symptoms associated with its loss.
• Regentis Biomaterials’ GelrinC is designed to support the body’s natural cartilage-regeneration process through a gradual, controlled repair environment.
• Early clinical data has provided encouraging evidence for GelrinC, which already has approval in Europe, while an FDA-authorized pivotal trial is advancing its development toward potential U.S. approval.

A knee that once carried a runner through marathons or a hiker up a steep mountainside can be sidelined by a single defect in cartilage. More broadly, nearly a half-million Americans end up with knee cartilage damage each year as a result of long-term wear and tear and every-day accidents. For decades, many available treatments have focused on managing pain and restoring functions rather than actually replacing damaged cartilage with healthy tissue. Regentis Biomaterials (NYSE American: RGNT) is pursuing a different approach with GelrinC, an off-the-shelf hydrogel implant designed to support the regeneration of cartilage within the damaged area.

Cartilage is very difficult for the body to repair on its own. Unlike many other tissues, it has limited blood supply, which can make significant injuries difficult to heal and leave patients vulnerable to persistent pain, stiffness and progressive joint degeneration. Researchers across the field, including teams at Duke University and the Mayo Clinic, have been exploring ways to encourage the body to regenerate healthier cartilage rather than simply treating the symptoms of its loss.

That broader research effort underscores the challenge Regentis is attempting to address. If damaged cartilage can be restored earlier in the disease process, the potential benefits could extend beyond short-term pain relief to preserving joint function and potentially altering a patient’s longer-term trajectory.

GelrinC takes a distinct approach to that challenge. The implant is delivered as a liquid directly into a cartilage defect and then cured in place using UV light, forming a soft, rubbery scaffold that conforms to the damaged area. Over approximately six to nine months, the scaffold gradually degrades, creating an environment intended to support the migration and organization of the body’s own cells as new cartilage develops.

That gradual timeline is deliberate; it is the core of GelrinC’s design. Rather than relying on a permanent implant or requiring cells to be harvested and expanded outside the body, GelrinC is intended to provide temporary structural support while the body’s natural repair mechanisms take over. Imaging of treated joints has shown regenerated tissue with characteristics closer to native hyaline cartilage than to the fibrous tissue typically produced by conventional techniques such as microfracture.

Importantly, the clinical case for GelrinC is supported by human data. In a Phase 2 study involving 56 patients followed for as long as four years across clinical sites in Israel and northern Europe, GelrinC met its primary efficacy endpoints. During the last two years, patients demonstrated improvements in Knee injury and Osteoarthritis Outcome Score (“KOOS”) and visual analog scale (“VAS”) pain measurements, with reported improvements approximately twice those observed with microfracture in the study’s comparative analysis. Patients continued to report improvements in pain and function through four years, while no serious adverse events were reported.

The procedure itself also offers a potential practical advantage. GelrinC can be administered in approximately 10 minutes and does not require cell harvesting, laboratory expansion or staged surgical procedures associated with certain cell-based cartilage therapies. That combination of an off-the-shelf implant and a streamlined procedure could help address some of the logistical and cost challenges associated with more complex regenerative approaches.

The next test is taking place on a much larger stage.

Regentis is advancing GelrinC through an FDA-authorized pivotal study across the United States and Europe, with the program designed to generate the two-year follow-up data needed to support a potential Premarket Approval submission. The pivotal program includes an initial cohort of 80 patients, with an additional 40 patients planned to be treated afterward.

The company has also reached an important international milestone with CE Mark approval in Europe, providing a pathway toward commercialization as its U.S. clinical program progresses. Together, the European regulatory achievement and ongoing U.S. pivotal study represent a transition for GelrinC from an investigational technology toward a potential commercial cartilage-repair product.

The market opportunity is significant. The U.S. knee cartilage repair market has been estimated at approximately $3 billion annually, encompassing roughly 470,000 procedures. Yet despite the size of the market, patients and physicians continue to face limitations in available cartilage-repair options. GelrinC’s off-the-shelf format could potentially offer an alternative to cell-based approaches that involve considerably more complex manufacturing and treatment processes.

That combination of unmet clinical need, an established development pathway and a potentially scalable treatment model is what makes Regentis one of the more compelling regenerative medicine stories to watch as GelrinC advances toward its next set of milestones.

For investors, the story ultimately comes down to whether the company’s early clinical results can be replicated in the pivotal program, where the two-year follow-up data supporting a Premarket Approval submission is the key catalyst ahead. If they are, GelrinC could emerge as a differentiated option in a market where physicians have long sought better ways to restore damaged cartilage and preserve joint function.

Regentis is therefore not simply developing another treatment for knee pain. It is pursuing a regenerative approach designed to work with the body’s own repair mechanisms, while offering the potential advantages of an off-the-shelf product and a relatively streamlined procedure. As the pivotal trial progresses and European commercialization develops, GelrinC is moving closer to answering a fundamental question in cartilage repair: whether damaged joints can be treated not merely to feel better, but to restore the tissue itself.

NOTE TO INVESTORS: The latest news and updates relating to RGNT are available in the company’s newsroom at ibn.fm/RGNT

This content was disseminated on behalf of (NYSE American: RGNT) as part of a paid marketing engagement with IBN.Ai

RGNT: IBN will receive $30,000 per quarter for a total of 180 days from RGNT for coverage via IBN

Please see full terms of use and disclaimers on the IBN website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

• The company has supported the launch of Sri Lanka’s first robotic cardiac surgery program at Kings Hospital Colombo using the SSi Mantra 3.0 surgical robotic system.
• The program began with a robotic-assisted LIMA takedown, performed by SS Innovations founder and Chairman Dr. Sudhir Srivastava alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva.
• Kings Hospital has completed more than 25 robotic procedures in three weeks, according to a recent company video describing the program’s early activity.
• SS Innovations reported 224 cumulative SSi Mantra installations across 12 countries at the end of the second quarter.
• The company’s second-quarter revenue reached $13.9 million, while robotic procedures increased 143% year over year to 2,528, pointing to rising utilization of the company’s installed base.
• The next major corporate milestone is regulatory expansion, with SS Innovations pursuing U.S. FDA clearance and European CE marking for the SSi Mantra system.

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is helping write a new chapter in Sri Lanka’s cardiac-surgery sector with the launch of the country’s first robotic cardiac surgery program at Kings Hospital Colombo, using the SSi Mantra 3.0 surgical robotic system.

The program began with a robotic-assisted left internal mammary artery (“LIMA”) takedown performed by Dr. Sudhir Srivastava, founder and chairman of SS Innovations, together with Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. The development was highlighted in a recent video from SS Innovations, which described the introduction of robotic cardiac surgery as an effort to expand access to minimally invasive procedures in Sri Lanka (https://ibn.fm/jAzkf). The hospital has already completed more than 25 robotic procedures during the first three weeks of the program.

The development gives SS Innovations another international reference point for its SSi Mantra platform as the company works to expand beyond its established Indian market.

Kings Hospital’s adoption of the SSi Mantra 3.0 is intended to expand the hospital’s capacity for robotic-assisted procedures while developing local expertise in the technology. The system incorporates stereoscopic 3D 4K visualization and robotic instrument control, allowing surgeons to perform procedures through smaller access points where clinically appropriate.

The Sri Lankan program also illustrates another aspect of robotic surgery: the transfer of specialized capabilities across national healthcare systems. For patients, greater availability of advanced procedures locally can reduce the need to travel overseas for selected treatments. For hospitals, installing robotic platforms can create a foundation for surgeon training and the development of additional minimally invasive programs.

SS Innovations has also developed its technology with future telesurgery applications in mind. To date the company has completed more than 25 cardiac telesurgeries using SSi Mantra. Telesurgery remains an emerging application requiring appropriate regulatory, clinical and technical infrastructure, rather than a mature commercial revenue stream for the company.

The Sri Lankan installation comes as SS Innovations reports increasing activity across its broader installed base.

A recent analysis by Lucid Capital Markets found that the company placed 30 SSi Mantra systems during the second quarter of 2026, ahead of the analyst’s expectation of 25. Cumulative installations reached 224 systems across 12 countries, compared with 194 at the end of the first quarter. First-half placements totaled 56 systems, versus 38 during the first half of 2025.

The company’s financial results provide another indication of the commercial trajectory. Second-quarter revenue reached $13.9 million, an increase of 39% from the year-earlier period. System sales rose 41% to $12.4 million, while gross margin was 50.9%.

More significant for the economics of a surgical robotics platform may be the increase in procedures performed on installed systems. SS Innovations reported 2,528 robotic surgeries during the second quarter, representing a 143% year-over-year increase. Cumulative procedures performed using SSi Mantra reached 12,272, including 637 cardiac procedures and 222 pediatric cases.

A larger installed base combined with rising procedure volumes can create opportunities for recurring revenue from instruments, accessories and other consumables used during surgery. That model is particularly relevant in India, where SS Innovations has spent several years establishing its presence and building a network of hospitals using SSi Mantra.

SS Innovations has often positioned SSi Mantra as a cost-conscious alternative in surgical robotics, but affordability is only one component of the company’s competitive proposition. The system is designed as a comprehensive robotic surgical platform capable of supporting multiple specialties, with high-definition three-dimensional visualization and multi-jointed instruments intended to give surgeons greater control during minimally invasive procedures.

The company’s international expansion now faces a more conventional biotechnology- and medical-device-style hurdle: regulatory approval. SS Innovations has submitted a 510(k) application to the U.S. Food and Drug Administration for SSi Mantra and is pursuing CE marking for the European Union. The company now expects FDA clearance by end of Q1 2027. Its target for CE marking remains the end of 2026.

For more information, visit the company’s website at www.SSInnovations.com.

NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII

• WRAP(R) is expanding beyond individual public safety technologies by integrating training, situational awareness, response capabilities, and continuous learning into a broader platform.
• Its relationship with WOFT Charities and Florida’s Teacher Safety Training Program demonstrates how WRAP’s training methodology can extend into new professional environments.
• The company’s Wrap Tactics(TM) learning management system could provide a scalable foundation for certification, recurring training, and broader adoption across education, private security, military, and other markets.

Public safety technology is increasingly moving beyond individual products as organizations seek solutions that combine technology with training, situational awareness, real-world scenarios, and continuous professional development. Wrap Technologies (NASDAQ: WRAP) is positioning itself at the intersection of these capabilities as it works to expand its public safety platform across a broader range of applications.

Known for its public safety platform and training capabilities, WRAP is increasingly applying its expertise beyond traditional law enforcement. That strategy was recently highlighted through the company’s selection by WOFT Charities to support Florida’s Teacher Safety Training Program, an initiative supported by approximately $475,000 in state funding. The full appropriation is not a direct award to WRAP and should not be read as future WRAP revenue.

The program is designed to provide practical safety and preparedness training for teachers, administrators, and other school personnel, with WRAP contributing methodologies centered on situational awareness, threat recognition, early intervention, and de-escalation. The state funding was awarded to WOFT, with WRAP compensated for the services it provides under the program.

For investors, however, the significance of the initiative may extend beyond the immediate engagement.

“Everything starts with awareness,” Jared Novick, President and Chief Operating Officer of WRAP, said, emphasizing the importance of recognizing threat indicators and understanding changing circumstances before situations escalate.

That philosophy is central to WRAP’s broader approach. Rather than viewing training as a standalone service, the company is integrating instruction, scenario-based learning, technology, and response capabilities into a connected ecosystem designed to help organizations prepare for and manage complex situations.

The WOFT relationship provides an early example of how that model can be applied outside traditional law enforcement. WRAP has exclusive access to WOFT’s training facility, creating an environment where instructors, methodologies, and technologies can be combined through realistic, scenario-based exercises.

“Real-world scenario training should not be limited to law enforcement,” Novick said, pointing to potential applications involving teachers, security professionals, military personnel, and other groups responsible for protecting themselves or others.

WRAP is also developing the infrastructure needed to support that expansion. Introduced as part of the WrapShield(TM) architecture, Wrap Tactics(TM) is intended to make training more consistent, measurable, certifiable, and auditable while supporting continued learning beyond a single in-person session.

That creates a potentially important distinction for WRAP. Rather than relying solely on individual training engagements, a digital learning infrastructure could allow the company to maintain longer-term relationships with organizations through recurring education, proficiency development, and certification.

The concept also fits into WRAP’s broader vision for integrated public safety capabilities. Its WrapShield(TM) platform brings together detection, orchestration, and response capabilities, while training provides the human component needed to help personnel interpret situations, make informed decisions, and effectively utilize available technologies. In this framework, training becomes more than a standalone service; it becomes an important layer connecting people, technology, and response.

Recent expansion into private security further demonstrates the potential reach of this approach. By extending its technology, training, and operational methodologies into new customer environments, WRAP is working to demonstrate that capabilities developed for law enforcement can be adapted to a wider range of organizations facing evolving safety requirements.

For investors, the opportunity may therefore be less about any single training contract and more about whether WRAP can turn its existing expertise into a repeatable platform serving multiple markets. Education, private security, military applications, and other professional environments could provide avenues for expansion, while digital training and certification may create additional opportunities for recurring engagement.

As Novick explained, “We believe the future of training is integrated,” bringing together instructors, methodology, real-world scenarios, continuous digital learning, and technology.

The WOFT initiative may therefore represent more than a single training engagement. It provides a tangible example of how WRAP can leverage its public safety expertise and training infrastructure across new markets while building toward a more integrated technology and learning platform.

As WRAP continues connecting training, technology, situational awareness, and response capabilities, its ability to scale that integrated model across different customer groups could become an increasingly important component of the company’s broader growth story.

For more information, visit the company’s website at wrap.com.

NOTE TO INVESTORS: The latest news and updates relating to WRAP are available in the company’s newsroom at ibn.fm/WRAP

About / Disclaimer

This article was produced by IBN Editorial Staff and is intended for informational purposes only. It is not investment advice and should not be relied upon as the basis for any investment decision. Statements attributed to Wrap Technologies Inc. or its management, including any forward-looking statements regarding revenue growth, product development, or market opportunities, reflect the company’s views and are subject to risks and uncertainties; actual results may differ materially. Readers should conduct their own due diligence and consult a qualified professional. Additional company information is available at wrap.com.

• TechForce Robotics uses AI-enhanced automation to help businesses address labor shortages, rising costs and operational inefficiencies.
• Its Robotics-as-a-Service Provider (“RaaSP”) model lowers barriers to adoption while creating potential recurring revenue opportunities.
• A potential deployment of up to 5,000 robotic systems with NBR Intelligence signals TechForce’s growing ambitions in industrial and factory automation.

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, is positioning itself among the several trends reshaping the global economy: persistent labor shortages, rising operating costs and accelerating adoption of AI-enhanced automation.

Global industrial robot installations reached 542,000 units in 2024, more than double the figure recorded a decade earlier, highlighting the growing role automation is playing in addressing workforce and productivity challenges. As the industry evolves, the opportunity is increasingly shifting from technological demonstrations to robots capable of performing reliably in real operating environments (ibn.fm/XvEVP).

TechForce Robotics is building its strategy around that transition. The company develops and integrates AI-enhanced robotics solutions across hospitality, food service, commercial and industrial applications, helping operators address repetitive tasks, workforce constraints and operational bottlenecks.

A core part of that strategy is Robotics-as-a-Service Provider (“RaaSP”). Rather than requiring customers to make large upfront investments in robotic equipment, the model is designed to provide deployment, maintenance and ongoing optimization through an extended service relationship. For TechForce, that approach can also create opportunities for recurring revenue as robotic systems remain under service agreements.

The company’s focus on real-world implementation is particularly relevant as robotics adoption accelerates. The International Federation of Robotics has observed that AI-enabled robots are increasingly moving beyond prototypes and into real-world deployment, placing greater emphasis on reliability, efficiency and measurable operational performance.

TechForce recently highlighted that deployment-focused strategy through a letter of intent with Singapore-based NBR Intelligence Pte. Ltd. The nonbinding framework contemplates a potential multi-site factory automation program involving up to 5,000 robotic systems, beginning with five initial pilot systems.

The proposed program would integrate TechForce’s AI-enhanced robotic systems with NBR’s MIDAS industrial intelligence platform, which is already deployed in live factory environments. Before any broader rollout, the companies plan to conduct operational, safety, network, facility and workflow assessments, followed by pilot evaluations against agreed-upon performance criteria. The proposed quantities and deployment schedule remain subject to site identification, pilot acceptance, financing and definitive agreements.

The contemplated rollout would begin with five pilot systems, with aggregate pilot pricing currently estimated at $250,000 to $350,000, including implementation services and initial nonrecurring engineering. If the pilots are successfully completed and accepted, the framework contemplates an initial scaled deployment of 100 cumulative systems, followed by a potential rollout of approximately 500 additional systems per month until the contemplated quantity is reached. The proposed figures are planning estimates and do not represent purchase orders, backlog or guaranteed revenue.

The workforce challenge behind the opportunity is substantial. NBR Intelligence CEO Rick Nguyen said “factories on the company’s network face staffing shortages, with annual turnover running at approximately 15% to 20%. For operators confronting persistent workforce constraints, automation can provide a way to increase production capacity while shifting human workers toward roles involving robot design, installation, programming and maintenance.”

“We are excited about the potential of this project,” said Jimmy Chan, CEO of Nightfood Holdings. “In addition to helping prospective site operators address ongoing labor shortages and production constraints, the contemplated automation program is designed to materially expand production capacity and create additional revenue opportunities for the targeted operations.”

For investors, the broader opportunity may lie in TechForce’s evolving deployment model. The company is pursuing applications across multiple service-intensive and industrial markets while emphasizing structured testing, systems integration and scalable deployment rather than technology development alone.

As labor shortages continue pushing businesses toward automation, companies capable of putting AI-enhanced robotics into work in real operating environments could benefit from expanding demand. TechForce Robotics is positioning its technology, RaaSP model and growing industrial ambitions to participate in that transition, with the NBR framework providing a potential pathway from pilot deployments toward larger-scale automation.

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

• The Texatron(TM) program has moved from prototype development into active testing, with the company reporting continued work on its 500 kW and 5 MW configurations.
• The company says repeatable pulsed magnetic-confinement tests have produced peak pressures of approximately 100,000 atmospheres, an experimental result that it is using to advance its deuterium–helium-3 (D–³He) fusion work.
• American Fusion(TM) is targeting D–³He fusion and is developing a pulsed magnetic-compression architecture rather than a conventional steady-state magnetic-confinement system.
• The company’s 5 MW pre-production Texatron(TM) has progressed through testing at Texas Tech University, following Texas regulatory approval for the company’s research systems.
• Harbinger Research has updated its coverage of American Fusion(TM), highlighting the transition into active testing, 100 pending U.S. patent applications, the OTCQB listing, and potential future technical and commercial milestones.

American Fusion(TM) (OTCBQ: AMFN), a developer of next-generation fusion energy technologies, is entering a more consequential phase of its fusion program as recent testing updates coincide with new equity research coverage examining the company’s progress toward commercial validation.

The Southlake, Texas-based company announced recently that its Texatron(TM) Fusion Engine(TM) development program had continued to produce repeatable magnetic-confinement results, including peak confinement pressures of approximately 100,000 atmospheres (https://ibn.fm/ITBKg). The company is now working to characterize the combination of temperature, density and confinement time required to advance toward D–³He fusion conditions.

The announcement was followed by an updated research report from Harbinger Research titled “Advancing Modular Fusion Power Toward Commercial Validation.” The report represents an update to Harbinger’s January coverage and assesses American Fusion’s development over the intervening eight months (https://ibn.fm/vnw6E).

The timing is significant because American Fusion(TM) has spent much of 2026 moving the Texatron(TM) from an engineering concept toward an instrumented testing program. In June, the company took delivery of its 5 MW pre-production Texatron(TM). By late July, testing had begun at Texas Tech University, where the company’s technical team carried out laboratory preparation and system evaluations. The initial phase was completed July 31.

The company had also received a Texas Department of State Health Services Certificate for Industrial Radiation Machines covering its registered Texatron(TM) research systems. That authorization supported research and development activities at the company’s testing location in Lubbock, Texas.

American Fusion(TM) is pursuing D–³He fusion, in which deuterium and helium-3 are intended to fuse and produce energetic charged particles. Its Texatron(TM) architecture uses short-duration electromagnetic pulses to compress and heat plasma rather than relying on the large, continuous magnetic fields associated with conventional tokamak-style systems.

The company says the approach is intended to bring temperature, pressure and density together with sufficient confinement time during the pulse. Its latest calculations examine two geometries: an approximately 11-inch chamber associated with a 500 kW development model and a 23-inch chamber associated with the approximately 5 MW configuration. Under the company’s modeled assumptions, the larger configuration contains substantially more plasma volume and therefore could support a greater quantity of reacting fuel if equivalent plasma conditions can ultimately be achieved.

American Fusion(TM) explicitly distinguishes modeled fusion reactions and instantaneous energy calculations from measured fusion output, net energy gain or continuous electrical generation. A successful fusion device must demonstrate that the relevant plasma conditions can be created and sustained sufficiently for fusion reactions to occur at useful rates, while managing energy losses. Achieving a particular pressure or temperature in isolation would not establish ignition.

That scientific distinction is also central to the updated Harbinger coverage. According to American Fusion(TM), the research report examines the company’s Texatron(TM) technology, testing program, intellectual-property portfolio, commercial strategy, capital structure and competitive environment. It also points to potential future catalysts including additional testing results, evidence of D–³He fusion, quantitative energy and power measurements, repeatability, independent validation and commercial agreements.

The report comes as the company says its U.S. patent portfolio has reached 100 pending applications. American Fusion(TM) has also advanced to the OTCQB Venture Market and established SEC-reporting status, developments that increase the amount of corporate and technical information available to public-market investors.

American Fusion(TM) also sees a commercial distinction in its proposed use of aneutronic fusion. Traditional fusion concepts generally seek to heat plasma and extract energy through a thermal cycle. The Texatron(TM) concept is intended to work with charged fusion products that could, in principle, be converted directly into electricity through electromagnetic systems rather than first producing steam to drive a turbine.

The company’s technology materials describe a modular architecture intended for applications ranging from distributed power to larger industrial and utility installations. That commercial ambition places the company in a market shaped by growing electricity requirements from data centers, advanced computing, industrial electrification and other power-intensive applications.

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to AMFN are available in the company’s newsroom at https://ibn.fm/AMFN

• Earth Science Tech has made meaningful progress over the last few years, building a business anchored in a conglomerate model, infrastructure as a service, and end-to-end vertical integration
• The company is focused on the seamless integration of patient care through its operating businesses that offer telemedicine and telehealth infrastructure for consultations and third-party providers, compounding services, and fulfilment
• ETST has leveraged vertical integration to not only support the operations of its businesses but also tap into both B2B and B2C segments for revenue and growth

Earth Science Tech (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, began the current fiscal year 2027 in a position of real financial strength, according to CEO and Board Chairman Giorgio R. Saumat letter to shareholders (https://ibn.fm/NC6CW). This position is the result of meaningful progress over the last several years, which built a business that is not only durable, self-sustaining, and positioned for long-term growth but also anchored in a conglomerate model, infrastructure as a service, and end-to-end vertical integration.

The company’s core value proposition is the seamless integration of patient care, from consultation (through telemedicine and telehealth platforms) and clinical support to compounding pharmacy operations and direct-to-patient fulfillment. The company provides this value through its operating businesses, which are strategically and vertically integrated: RxCompoundStore.com LLC (“RxCS”), Mister Meds LLC, Zoolzy LLC, Meduvo LLC, Peaks Curative LLC (“Peaks”), DOConsultation.com LLC (“DOC”), Las Vilas Health Care, Avenvi LLC, and MagneChef.

RxCS is a Miami-based licensed pharmacy that compounds sterile and non-sterile medication, while Mister Meds is an Abilene-based pharmacy that compounds sterile drugs and is licensed to handle hazardous drugs. Meduvo is Earth Science Tech’s recently acquired La Verne-based compounding pharmacy that makes and dispenses non-sterile medication. Combined, these compounding pharmacies are licensed in 34 jurisdictions in the United States (https://ibn.fm/Kw23s).

Earth Science Tech recently completed the acquisition of Zoolzy, a Doral-based wholesale distributor of active pharmaceutical ingredients (“APIs”) and finished FDA-approved prescription products (https://ibn.fm/hHh5K). The acquisition taps into a new vertical and enables the company’s compounding pharmacies to secure essential raw materials at competitive wholesale prices, thus supporting ETST’s strategy to vertically integrate its operations end-to-end.

The vertical integration strategy is also evident in the operations of other subsidiaries, including Peaks and DOC. Peaks is a telemedicine referral platform that offers asynchronous consultation for compounded drugs, while DOC is a telehealth brand through which a team of medical experts offers virtual consultations and treatments, with prescriptions fulfilled by ETST’s compounding pharmacies.

Besides supporting vertical integration, the company’s telehealth and telemedicine platforms and compounding pharmacies serve a second purpose: they ensure that ETST not only sells products to consumers but also provides medical consultation tech infrastructure and compounding services to third-party providers and companies. As a result, ETST generates high-margin B2B revenue to supplement B2C revenue from consumers.

Earth Science Tech continues to leverage its conglomerate model, infrastructure-as-a-service, and vertical integration as well as optimized operational frameworks to drive growth and support scalable, sustainable expansion. And as Mr. Saumat stated in his letter, management expects “every company under the ETST umbrella to expand its geographic footprint this year” and that the company “will pursue acquisitions and/or partnerships where they help us meet that goal.” 

For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST 

• The company’s original flagship asset is Skaergaard, a palladium-gold-platinum deposit in southeast Greenland.
• Greenland Mines has completed its acquisition of Neo North Star Resources Inc., bringing the Sarfartoq rare earths project in southwest Greenland into the company’s portfolio.
• Both projects sit inside Greenland, a jurisdiction the company describes as mining friendly, with a modern regulatory regime and no third-party royalties layered onto either asset.

Junior mining stocks live and die by a single number: The price of whatever metal sits beneath their flagship projects. When that price falls, so does the company, regardless of how good the geology is. It is a structural weakness baked into most explorers’ business models, and it explains why single-asset miners trade at a discount and swing wildly with commodity headlines. Greenland Mines (NASDAQ: GRML) is ensuring it doesn’t operate in that space, having transformed from a company built around one palladium-gold-platinum deposit into one that now also controls a major rare earths project, a shift that creates a different view for interested investors.

The company’s original flagship asset is Skaergaard, a palladium-gold-platinum deposit in southeast Greenland. An updated 2026 mineral resource estimate, prepared by independent consultant SLR Consulting under the SEC’s S-K 1300 disclosure standard, put indicated resources at 15.0 million ounces of palladium-equivalent metal. Inferred resources came in at 17.49 million ounces, figures the company describes as making Skaergaard one of the largest undeveloped deposits of its kind. That is a substantial, de-risked technical foundation. But it is also, by definition, a bet on three closely related metals whose prices tend to move together through industrial and precious metals cycles.

That single-metal-family concentration is exactly what Greenland Mines set out to address next. Earlier this year,Greenland Mines signed a definitive agreement to acquire Neo North Star Resources Inc., and on September 1, 2026, following formal approval from the government of Greenland, the acquisition closed. Neo North Star owned the Sarfartoq rare earths project in southwest Greenland, which Greenland Mines bought from stockholders including Neo Performance Materials for $20 million in cash and $15 million in securities value. 

Neo Performance Materials became a strategic shareholder of Greenland Mines as part of the deal and retains offtake rights for up to 60% of future Sarfartoq production, to be processed at its Silmet facility in Estonia. Sarfartoq is a carbonatite-hosted deposit built around neodymium and praseodymium. Those two rare earth elements go into the permanent magnets found in electric vehicle motors, wind turbines and defense systems. That is a fundamentally different commodity story than palladium and gold, driven by electrification and supply-chain policy rather than jewelry demand or catalytic converter volumes.

The distinction matters more than it might first appear. Palladium and platinum prices are closely tied to internal combustion and hybrid vehicle production, an industry facing long-term structural headwinds from electrification. Gold tends to move on interest rates, inflation expectations and safe-haven demand. Neodymium and praseodymium, by contrast, are levered to the buildout of electric motors and wind turbines, a demand curve that runs largely independent of the first two. Owning meaningful exposure to both baskets means a downturn in one commodity complex does not automatically translate into a company-wide crisis.

Geography reinforces the diversification. Both projects sit inside Greenland, a jurisdiction the company describes as mining friendly, with a modern regulatory regime and no third-party royalties layered onto either asset. That single-country footprint keeps political and permitting risk consistent across the portfolio, even as the underlying commodities diverge. It is a cleaner risk structure than juggling projects spread across multiple regulatory regimes.

There is also a policy tailwind specific to Sarfartoq that Skaergaard does not share. Global neodymium-praseodymium supply remains heavily concentrated outside the western hemisphere. Recent export restrictions have intensified pressure on the United States, Europe and allied nations to secure independent sources. Sarfartoq’s core ST1 zone carries a neodymium-praseodymium ratio of 25–40% of total rare earth oxides. That is among the highest such ratios reported anywhere in the world. That kind of concentration is unusual, giving the project relevance to western critical-minerals policy that a pure precious-metals deposit does not carry on its own.

None of this eliminates the risks inherent to early-stage mining companies. With the Sarfartoq acquisition now closed, Greenland Mines moves from deal-making to execution, advancing the project toward a prefeasibility study through infill drilling, metallurgical test work and continued permitting. Both projects still need time before production, with resource figures not yet showing economic viability. Commodity diversification reduces single-metal exposure; it does not remove risk.

Still, the strategic logic is straightforward. A company holding two projects across two distinct commodity cycles, inside one stable jurisdiction, offers a different risk-reward proposition than a peer betting everything on a single metal’s next price cycle. For a small-cap miner, that kind of structural diversification is not something investors can build for themselves by holding one stock. It has to be built into the company itself, and Greenland Mines has spent this year doing exactly that.

For more information, visit www.GreenlandMines.com.

NOTE TO INVESTORS: The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML